Preliminary clinical study of personalized neoantigen vaccine therapy for microsatellite stability (MSS)-advanced colorectal cancer
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1432-0851
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Preliminary clinical study of personalized neoantigen vaccine therapy for microsatellite stability (MSS)-advanced colorectal cancer ; day:16 ; month:2 ; year:2023 ; pages:1-12
Cancer immunology immunotherapy ; (16.2.2023), 1-12
- Creator
-
Yu, Yao-Jun
Shan, Na
Li, Li-Yi
Zhu, Yue-Sheng
Lin, Li-Miao
Mao, Chen-Chen
Hu, Ting-Ting
Xue, Xiang-Yang
Su, Xiao-Ping
Shen, Xian
Cai, Zhen-Zhai
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s00262-023-03386-7
- URN
-
urn:nbn:de:101:1-2023041921131337211263
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 11:00 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Yu, Yao-Jun
- Shan, Na
- Li, Li-Yi
- Zhu, Yue-Sheng
- Lin, Li-Miao
- Mao, Chen-Chen
- Hu, Ting-Ting
- Xue, Xiang-Yang
- Su, Xiao-Ping
- Shen, Xian
- Cai, Zhen-Zhai
- SpringerLink (Online service)
Other Objects (12)
Personalized neoantigen-pulsed dendritic cell vaccines show superior immunogenicity to neoantigen-adjuvant vaccines in mouse tumor models
Spleen‐targeted neoantigen DNA vaccine for personalized immunotherapy of hepatocellular carcinoma
TruNeo: an integrated pipeline improves personalized true tumor neoantigen identification
Personalized neoantigen cancer vaccines: current progression, challenges and a bright future
A comprehensive proteogenomic pipeline for neoantigen discovery to advance personalized cancer immunotherapy
Sulfonium‐Stapled Peptides‐Based Neoantigen Delivery System for Personalized Tumor Immunotherapy and Prevention
Personalized neoantigen vaccine prevents postoperative recurrence in hepatocellular carcinoma patients with vascular invasion
Personalized neoantigen vaccine and pembrolizumab in advanced hepatocellular carcinoma: a phase 1/2 trial
Personalized, autologous neoantigen-specific T cell therapy in metastatic melanoma: a phase 1 trial
Benefits of an Immunogenic Personalized Neoantigen Nanovaccine in Patients with High‐Risk Gastric/Gastroesophageal Junction Cancer
Personalized neoantigen vaccines as early intervention in untreated patients with lymphoplasmacytic lymphoma: a non-randomized phase 1 trial
Neoantigen vaccine: an emerging tumor immunotherapy
Personalized neoantigen-pulsed dendritic cell vaccines show superior immunogenicity to neoantigen-adjuvant vaccines in mouse tumor models
Spleen‐targeted neoantigen DNA vaccine for personalized immunotherapy of hepatocellular carcinoma
TruNeo: an integrated pipeline improves personalized true tumor neoantigen identification
Personalized neoantigen cancer vaccines: current progression, challenges and a bright future
A comprehensive proteogenomic pipeline for neoantigen discovery to advance personalized cancer immunotherapy
Sulfonium‐Stapled Peptides‐Based Neoantigen Delivery System for Personalized Tumor Immunotherapy and Prevention
Personalized neoantigen vaccine prevents postoperative recurrence in hepatocellular carcinoma patients with vascular invasion
Personalized neoantigen vaccine and pembrolizumab in advanced hepatocellular carcinoma: a phase 1/2 trial
Personalized, autologous neoantigen-specific T cell therapy in metastatic melanoma: a phase 1 trial
Benefits of an Immunogenic Personalized Neoantigen Nanovaccine in Patients with High‐Risk Gastric/Gastroesophageal Junction Cancer
Personalized neoantigen vaccines as early intervention in untreated patients with lymphoplasmacytic lymphoma: a non-randomized phase 1 trial
Neoantigen vaccine: an emerging tumor immunotherapy
Personalized neoantigen-pulsed dendritic cell vaccines show superior immunogenicity to neoantigen-adjuvant vaccines in mouse tumor models
Spleen‐targeted neoantigen DNA vaccine for personalized immunotherapy of hepatocellular carcinoma
TruNeo: an integrated pipeline improves personalized true tumor neoantigen identification
Personalized neoantigen cancer vaccines: current progression, challenges and a bright future
A comprehensive proteogenomic pipeline for neoantigen discovery to advance personalized cancer immunotherapy
Sulfonium‐Stapled Peptides‐Based Neoantigen Delivery System for Personalized Tumor Immunotherapy and Prevention
Personalized neoantigen vaccine prevents postoperative recurrence in hepatocellular carcinoma patients with vascular invasion
Personalized neoantigen vaccine and pembrolizumab in advanced hepatocellular carcinoma: a phase 1/2 trial
Personalized, autologous neoantigen-specific T cell therapy in metastatic melanoma: a phase 1 trial
Benefits of an Immunogenic Personalized Neoantigen Nanovaccine in Patients with High‐Risk Gastric/Gastroesophageal Junction Cancer
Personalized neoantigen vaccines as early intervention in untreated patients with lymphoplasmacytic lymphoma: a non-randomized phase 1 trial